| COMPOSITION: | Each hard gelatin capsule contains enteric coated Esomeprazole Magnesium Trihydrate eq. to Esomeprazole 40 mg & Levosulpiride SR 75 mg |
| FORMULATION: | CAPSULE |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | ESOMEFOL-SL is a combination capsule containing Esomeprazole, a proton pump inhibitor (PPI), and Levosulpiride, a prokinetic agent. Esomeprazole reduces gastric acid secretion by inhibiting the H⁺/K⁺-ATPase enzyme system, providing effective relief in acid-related disorders. Levosulpiride enhances gastric motility and regulates gut-brain signaling by blocking dopamine D2 receptors. Together, they offer synergistic relief in acid reflux, GERD, functional dyspepsia, and gastric motility disorders. |
| SIDE EFFECTS: | Generally well tolerated. Possible side effects include headache, nausea, abdominal discomfort, dizziness, or diarrhea. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
